Phase I Study of Single-Agent KGX105 in Patients With Advanced or Metastatic Solid Tumors

NCT07702955 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

85

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced or Metastatic Solid Tumors

Interventions

DRUG: KGX105 injection

Sponsor

Kangabio AUSTRALIA LTD PTY